文献速递肝病消化道肿瘤与早癌

丁型肝炎病毒感染显著增加病毒性乙型肝炎肝硬化患者肝细胞癌风险

Hepatitis D Virus Infection Markedly Increases the Risk of Hepatocellular Carcinoma in Patients With Viral B Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-10-24

研究比较法国ANRSCO12 CirVir和DeltaVir队列中142例HBV-HDV共感染与271例HBV单感染肝硬化患者的HCC发生率。调整年龄后,共感染组1、3、5年累积HCC发生率分别为5.2%、11.8%、20.2%,单感染组为1.1%、2.5%、4.4%(P < .001)。多因素分析显示HDV感染是HCC的独立危险因素(HR 2.94,95%CI 1.19-7.25,P = .019)。

要点

  • HBV-HDV共感染肝硬化患者5年累积HCC发生率为20.2%,高于HBV单感染者的4.4%。
  • HDV感染是HCC的独立危险因素(HR 2.94,95%CI 1.19-7.25,P = .019)。
  • HDV共感染并非肝失代偿、移植或死亡的独立因素。

核心结论

  • HBV-HDV共感染肝硬化患者的HCC发生率似乎显著高于HBV单感染肝硬化患者。
  • HDV感染是HCC的独立危险因素,提示在肝硬化患者中HDV独立于HBV对HCC起致病作用。
  • HDV共感染并非肝失代偿、移植或死亡的独立因素。

研究设计与样本

  • 研究纳入法国ANRSCO12 CirVir和DeltaVir队列中组织学证实的肝硬化且无失代偿史的患者,包括142例HBV-HDV共感染和271例HBV单感染患者。

主要发现

  • HBV-HDV患者较HBV患者年轻(37.2岁 vs 53.8岁),更多来自撒哈拉以南非洲移民,合并症较少且肝功能检查异常更多。
  • 调整年龄后,共感染组与单感染组1年累积HCC发生率分别为5.2% vs 1.1%,3年为11.8% vs 2.5%,5年为20.2% vs 4.4%(P < .001)。
  • 多因素分析中,HDV感染与HCC发生独立相关(HR 2.94,95%CI 1.19-7.25,P = .019)。
  • 其他独立因素包括年龄(HR 1.08,95%CI 1.05-1.11,P < .001)、超重(HR 0.45,95%CI 0.22-0.93,P = .031)、吸烟(HR 2.26,95%CI 1.23-4.16,P = .009)、γ-谷氨酰转移酶升高(HR 2.73,95%CI 1.24-6.00,P = .013)、总胆红素>17 μmol/L(HR 2.68,95%CI 1.33-5.42,P = .006)和血小板计数<150.000/mm3(HR 3.11,95%CI 1.51-6.41,P = .002)。

关键数值与推荐

  • 调整年龄后,HBV-HDV共感染组1、3、5年累积HCC发生率分别为5.2%、11.8%、20.2%,HBV单感染组分别为1.1%、2.5%、4.4%(P < .001)。
  • HDV感染与HCC发生的独立关联:HR 2.94(95%CI 1.19-7.25,P = .019)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The specific causative role of hepatitis delta virus (HDV) infection in the development of hepatocellular carcinoma (HCC) remains debated and was not specifically demonstrated in patients with cirrhosis. Here we compared HCC incidence in hepatitis B virus (HBV)-HDV coinfected and HBV monoinfected patients with cirrhosis. METHODS: A total of 142 HBV-HDV and 271 HBV-infected patients with cirrhosis from the French ANRSCO12 CirVir and DeltaVir cohorts, with histologically proven cirrhosis and no history of decompensation, were included in the study. RESULTS: HBV-HDV patients were younger than HBV patients (37.2 vs 53.8 years), they were more often immigrants from sub-Saharan Africa, and displayed less comorbidities and more altered liver tests. After adjustment for age, cumulative incidences of HCC in coinfected and monoinfected patients at 1, 3, and 5 years were 5.2%, 11.8%, and 20.2% versus 1.1%, 2.5%, and 4.4%, respectively (P < .001). In multivariate analysis, HDV infection was an independent factor associated with the development of HCC (hazard ratio [HR], 2.94; 95% confidence interval [CI], 1.19-7.25; P = .019). Other independent factors were age (HR, 1.08; 95% CI, 1.05-1.11; P < .001), overweight (HR, 0.45; 95% CI, 0.22-0.93; P = .031), smoking (HR, 2.26; 95% CI, 1.23-4.16; P = .009), increased γ-glutamyltransferase (HR, 2.73; 95% CI, 1.24-6.00; P = .013), total bilirubin >17 μmol/L (HR, 2.68; 95% CI, 1.33-5.42; P = .006), and platelet count <150.000/mm3 (HR, 3.11; 95% CI, 1.51-6.41; P = .002). HDV coinfection was not an independent factor of liver decompensation, transplantation, or death. CONCLUSIONS: The incidence of HCC seems significantly higher in HBV-HDV than in HBV-infected patients with cirrhosis. HDV infection emerges as an independent risk factor for HCC, indicating that in patients with cirrhosis, HDV plays a causative role for HCC independently of HBV.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Roulot D, Layese R, Brichler S, et al. Hepatitis D Virus Infection Markedly Increases the Risk of Hepatocellular Carcinoma in Patients With Viral B Cirrhosis. Clin Gastroenterol Hepatol. 2024. PMID: 39461464. doi:10.1016/j.cgh.2024.08.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。